Detection of Fusobacterium in oral and head and neck cancer samples: A systematic review and meta-analysis

•Fusobacterium is present and in higher abundance in oral/head and neck cancer samples when compared to healthy samples.•The most common detection methods of Fusobacterium in head and neck cancer samples are based on molecular evidence.•F. nucleatum is the most prevalent species in head and neck can...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Archives of oral biology Ročník 112; s. 104669
Hlavní autoři: Bronzato, Juliana D, Bomfim, Rafael A, Edwards, David H, Crouch, Dorothy, Hector, Mark P, Gomes, Brenda P F A
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier Ltd 01.04.2020
Témata:
Fusobacteria
Fusobacterium
Fusobacterium nucleatum
Head and neck cancer
Oral cancer
Head and neck cancer
Oral cancer
Fusobacterium nucleatum
Fusobacteria
Fusobacterium
ISSN:0003-9969, 1879-1506, 1879-1506
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:•Fusobacterium is present and in higher abundance in oral/head and neck cancer samples when compared to healthy samples.•The most common detection methods of Fusobacterium in head and neck cancer samples are based on molecular evidence.•F. nucleatum is the most prevalent species in head and neck cancer.•Fusobacterium may contribute to oral/head and neck cancer development. This systematic review aimed to analyse: a) the presence and the abundance of Fusobacterium; b) the Fusobacterium species most often found, and c) the most common methods used for their identification in oral/head and neck cancer samples. A protocol was registered on PROSPERO database. This review was conducted following PRISMA guidelines. Literature search was performed on five electronic biomedical databases, namely Pubmed, Scopus, Web of Science, Embase, and Cochrane from their start dates to 30 August 2018. Two reviewers independently assessed the eligibility for inclusion; extracted the data; and evaluated the risk of bias. From 118 unique abstract records, 88 full-text articles were assessed for eligibility. According to inclusion and exclusion criteria, 17 publications were included in this review. Meta-analysis showed an increased prevalence of 6 % (95 % CI, 3–9) of Fusobacterium in tumour lesions than in non-tumour lesions (Fusobacterium prevalence of 16 % in tumour lesions and of 10 % in non-tumour lesions), and a 2.93 higher chance of Fusobacterium being present in tumour lesions (95 % CI, 1.47–5.81). The most common detection methods were based on molecular evidence (64.70 %) (95 % CI, 37.7–84.7). F. nucleatum was the most prevalent species (47.06 %) (95 % CI, 23.5–72). In conclusion, Fusobacterium is present and in higher abundance in oral/head and neck cancer samples when compared to non-cancer samples, suggesting that Fusobacterium may contribute to oral/head and neck cancer development.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0003-9969
1879-1506
1879-1506
DOI:10.1016/j.archoralbio.2020.104669